Sanofi CEO Sets Growth Target For Consumer Health Business
This article was originally published in The Pink Sheet
Executive Summary
CEO Brandicourt looks to Alan Main to lead return to mid-single-digit growth for consumer brands.
You may also be interested in...
Sanofi CEO Upbeat Despite Medivation M&A Miss, Sarilumab Diss
During third-quarter earnings report, Brandicourt said he remains confident about Sanofi's prospects in oncology despite losing the takeover fight for Medivation, although he didn't rule out another mid-sized bolt-on attempt if the opportunity arose.
Sanofi Creates Consumer Unit With Eye To Expansion
Former Bayer executive Alan Main tapped to lead Consumer HealthCare global business unit, which Sanofi will consider expanding through acquisitions after integrating OTC brands added in a recent swap with Boehringer Ingelheim.
Sanofi Adds Consumer Brands, Grows Footprint With Boehringer Ingelheim Deal
BI international brands including Mucoangin cough suppressant and Dulcolax constipation treatment and US heartburn remedy Zantac would join Sanofi's consumer portfolio including US brands Allegra Allergy antihistamines and Nasacort Allergy 24HR nasal decongestant in the firm's proposed asset swap.